Autopsy report · NCT04283513

Treatment of Hemorrhagic Fever With Ribavirin

“Product expired, new lots not available”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 8 months before it started.
• Suspended: paused, and may or may not restart.
• 50 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 2

Sponsor

U.S. Army Medical Research and Development Command

Sponsor type

US federal agency

Conditions

Hemorrhagic Fever

Interventions

Virazole

Participants

50 (planned, not actual)

Sites

1

Countries

Germany

Trials that died the same way

• Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
  “Product no longer on the market” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.